MDA Space walked into this earnings print with a flat 30 day share performance and a stock at CA$48.22 that had barely moved over three months, despite a sharp 7 day pop. The market was undecided on whether this space story still earned its rich P/E multiple. The headline today is simple. Revenue landed at CA$498.6m for Q2 and adjusted EBITDA margin sat around the high teens, yet basic earnings per share slipped quarter on quarter. The tension for investors is between strong top line momentum and a clear squeeze on profit per share.
Is MDA Space a growth story priced for perfection, or a genuine mispricing at 73.8x trailing P/E against peers? See whether the current share price lines up with intrinsic value in our valuation analysis for MDA Space
Prefer clear visuals instead of another dense wall of earnings tables and ratios? View MDA Space's full financial picture, including an at-a-glance summary of its valuation, in the company report for MDA Space.
Bulls argue MDA Space is building a full spectrum space platform that can scale high volume satellites, convert contract wins into durable backlog, and eventually support stronger cash generation. The Q2 numbers show several of those building blocks in place. Revenue grew strongly across the first half and adjusted EBITDA margins held around 19%, which suggests the current mix of satellite manufacturing, robotics and geo-intelligence is already supporting healthy unit economics at higher volumes.
The growth story also leans heavily on visible work for years ahead. Reported backlog reached about CA$4.0b and rises to roughly CA$4.4b including the post quarter Telesat expansion. A Q2 book to bill of 1.6x points to new awards running ahead of revenue recognition. The Montreal high volume plant is open and management states there are no capacity constraints today, which is consistent with the thesis that MDA Space can take on larger constellation programs without immediate bottlenecks.
See how these high volume satellite wins, growing backlog and steady adjusted EBITDA margins compare with institutional expectations with the consensus price target analysis for MDA Space.Bears worry that MDA Space is overexposed to a handful of big government and anchor commercial programs, that execution will wobble as the company scales, and that recent deals will stretch the balance sheet. Q2 does not remove those concerns, but it also does not clearly prove them right.
The revenue jump to CA$499m and 1.6x book to bill show large contracts are still converting into work. However, basic EPS slipped despite flat net income, reflecting recent equity issuance, which is exactly the dilution bears flagged from the CLS fundraise. H1 operating cash flow was slightly negative, so cash conversion has not yet caught up with reported EBITDA. The Canadarm3 scope reset also shows how program changes can alter long dated work. With CA$600m of new notes at 6.50% and two sizeable acquisitions still to integrate, balance sheet and execution risk remains a live test for the next few quarters.
After shareholder dilution, lower profit margins and recent insider selling, you may want to review our full risk analysis for MDA Space which shows 4 important warning signsIf the mix of strong Q2 revenue for MDA Space and pressure on basic EPS has your attention, register for free with Simply Wall St and add it to a Watchlist to track share price against fair value and watch how the story develops. Once you decide to take a position, use the Portfolio Command Center to keep your holdings organised and to surface only the most important alerts on fundamentals, valuation and risks. For a longer term view, lean on the Community to see how other investors are interpreting new contracts, cash flow trends and balance sheet moves. This can help you identify potential catalysts and downside flags early so you can stay a step ahead of the market.
Fresh ideas can move fast. Some stocks are building breakout momentum while others stay under the radar for now. Before the best entry points are caught by the crowd, act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com